Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $45.69 Analyst target: $56.21 Upside: 23.02%
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
See the full interactive analysis & chart →Informational only — not investment advice.